Objective: Type 2 diabetes mellitus (DM) is a chronic disease characterized by abnormal carbohydrate metabolism and in general requires long-term intensive glycemic control. Parenteral insulin treatment can promptly bring about well-controlled blood glucose. However, most patients are concerned about an elevation in their body weight and therefore decline the basal insulin treatment. The purpose of this study is aimed at exploring the well-being of patients by examining improvements in glycosylated hemoglobin (HbA1c) and changes in body weight after one year of basal insulin treatment. Methods: The study was carried out at a Metabolic Clinic at Taipei City Hospital from January to May, 2008. Study subjects were type 2 DM patients who routinely visiting the clinic and received complete follow-up studies over a one-year period. Clinic data and demographic data were collected including sex, age and education level. After one year of basal insulin treatment, any changes in HbA1c and body weight were recorded and statistically analyzed using the paired t-test. Results: In total, 323 patients participated in this study, of which 155 were male and 168 were female. The average of age of the patients was 63.7 years. The average HbA1c was 8.8%, and the average of body weight was 65.2 kg. After one year of basal insulin treatment, the HbA1c value had dropped on average by 0.56% and body weight had increased on average by 1.48 kg; both values were statistically significant (p<0.0001). Conclusion: Among type 2 diabetic patients who have been treated with basal insulin for a whole year, it was found that HbA1c was significantly improved, while body weight had increased. In light of these finding, it seem that it would be beneficial to patients if their anxiety with respect to body weight elevation was mitigated.
Objective: Type 2 diabetes mellitus (DM) is a chronic disease characterized by abnormal carbohydrate metabolism and in general requires long-term intensive glycemic control. Parenteral insulin treatment can promptly bring about well-controlled blood glucose. However, most patients are concerned about an elevation in their body weight and therefore decline the basal insulin treatment. The purpose of this study is aimed at exploring the well-being of patients by examining improvements in glycosylated hemoglobin (HbA1c) and changes in body weight after one year of basal insulin treatment. Methods: The study was carried out at a Metabolic Clinic at Taipei City Hospital from January to May, 2008. Study subjects were type 2 DM patients who routinely visiting the clinic and received complete follow-up studies over a one-year period. Clinic data and demographic data were collected including sex, age and education level. After one year of basal insulin treatment, any changes in HbA1c and body weight were recorded and statistically analyzed using the paired t-test. Results: In total, 323 patients participated in this study, of which 155 were male and 168 were female. The average of age of the patients was 63.7 years. The average HbA1c was 8.8%, and the average of body weight was 65.2 kg. After one year of basal insulin treatment, the HbA1c value had dropped on average by 0.56% and body weight had increased on average by 1.48 kg; both values were statistically significant (p<0.0001). Conclusion: Among type 2 diabetic patients who have been treated with basal insulin for a whole year, it was found that HbA1c was significantly improved, while body weight had increased. In light of these finding, it seem that it would be beneficial to patients if their anxiety with respect to body weight elevation was mitigated.